• Pakistan Army donates vaccine, given by China, to frontline health workers
• CanSinoBio shows 74.48pc efficacy at preventing symptomatic cases
ISLAMABAD: While as many as 1,037 more cases of Covid-19 with positivity rate of 3.2 per cent were reported in a single day, the overall figure of deaths crossed the number of 12,000.
Moreover, the Independent Data Monitoring Committee (IDMC) has released analysis of CanSinoBio which showed that in Pakistan there was 74.48pc efficacy at preventing symptomatic cases and 100pc at preventing severe disease. However, international data of five countries showed 65.7pc efficacy at preventing symptomatic cases and 90.98pc at preventing severe disease.
According to data of the National Command and Operation Centre (NCOC), released on Monday, since the start of the pandemic on Feb 26, 2020, as many as 12,026 deaths were reported. Of which, 4,900 deaths were reported from Punjab, 4,119 from Sindh and 1,957 from Khyber Pakhtunkhwa (KP). Isl
The vaccine developed by Chinese firm CanSinoBIO and a team led by Chen Wei, Beijing s top military bio-warfare expert, is reported to show 65.7 per cent efficacy in preventing symptomatic cases.
China’s CanSino vaccine is 74.8% effective in preventing COVID-19, Special Assistant to the PM for Health Dr Faisal Sultan said late Monday. Dr Sultan said that the vaccine proved 100% effective at preventing severe diseases in the group of volunteers from Pakistan. He congratulated the health workers for conducting successful trials across the country. In the Pakistani subset, efficacy at preventing symptomatic cases is 74.8% & 100% at preventing severe disease. The IDMC didn t report any serious safety concerns. Data incld 30,000 participants & 101 virologically confmd COVID cases Well done Pak team for conducting this trial Faisal Sultan (@fslsltn) February 8, 202.